COMMUNIQUÉS West-GlobeNewswire

Nohla Therapeutics Announces Hiring of Jim Johnson as Chief Financial Officer
04/01/2018
SEATTLE, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading cell therapy company that provides a short-term bridge to long-term health for patients with critical diseases, today announced the [...]
Stop e-Prescribing Bill, Says President of the Association of American Physicians and Surgeons
04/01/2018
TUCSON, Ariz., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Forcing doctors to electronically prescribe all controlled drugs, as in Oklahoma proposed bill Req. No. 8141 , is a “flawed and misguided” idea that will not reduce [...]
Accelerate Diagnostics to Present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco
04/01/2018
TUCSON, Ariz., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the 36th Annual J.P. Morgan Healthcare [...]
Tauriga Sciences Inc. Completes Purchase of its First Tranche of Crypto Currency Groestlcoin
04/01/2018
NEW YORK, NY, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
Eloxx Pharmaceuticals Chairman and CEO Robert Ward to Participate in a Panel Discussion at the Biotech Showcase 2018 Conference
04/01/2018
WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (OTC:SVOND), a clinical-stage biopharmaceutical company developing novel small molecule medicines to treat rare and ultra-rare [...]
LHC Group to Present at 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
LAFAYETTE, La., Jan. 04, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG ) announced today that Keith G. Myers, chief executive officer of LHC Group, will present at the 36 th Annual J.P. Morgan Healthcare [...]
Tempus and Vanderbilt-Ingram Cancer Center Announce Data Initiative to Improve Outcomes for Cancer Patients
04/01/2018
CHICAGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram [...]
NeuroMetrix CEO to Participate in CES 2018 Panel on Opioid Crisis
04/01/2018
WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will participate in a panel at the Digital [...]
WishBone Medical, Inc. Names Andrew J. Miclot as President
04/01/2018
WARSAW, Ind., Jan. 04, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a new global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants in sterile packed, single-use [...]
INC Research/inVentiv Health Becomes Syneos Health™
04/01/2018
RALEIGH, N.C., Jan. 04, 2018 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq: INCR ) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. More than 21,000 of the [...]
CASMED Reports Preliminary Net Sales for the 2017 Fourth Quarter
04/01/2018
BRANFORD, Conn., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports preliminary unaudited topline results for the [...]
Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients
04/01/2018
NOVATO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
Sienna Biopharmaceuticals to Present at J.P. Morgan Healthcare Conference
04/01/2018
WESTLAKE VILLAGE, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of [...]
Houston Dermatologist Reveals Laser Treatment Options for Birthmarks
04/01/2018
HOUSTON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Most birthmarks, including Becker’s Nevus and Nevus of Ota , do not pose a threat to one’s health, explains Houston dermatologist Paul M. Friedman, MD. However, he says that [...]
Adverum Biotechnologies Provides 2018 Outlook
04/01/2018
MENLO PARK, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Rexahn Pharmaceuticals Announces the Appointment of Douglas J. Swirsky as President and Chief Financial Officer
04/01/2018
ROCKVILLE, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today [...]
WellDoc Validates Potential of Its Digital Therapeutic, BlueStar®, to Significantly Reduce Healthcare Costs
04/01/2018
COLUMBIA, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, announced today that its clinically proven hemoglobin A1C reductions for users of its BlueStar® digital therapeutic with type [...]
CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery
04/01/2018
OXNARD, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced the launch of their new brand initiative, inspired by the [...]
Envigo Allocates $300 Million Term Loan B Facility
04/01/2018
EAST MILLSTONE, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Envigo , a leading provider of non-clinical contract research services and research models, today announced it has allocated a $300 million offering of senior [...]

Pages